Carolinas Wealth Consulting’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-58
Closed -$3.49K 445
2025
Q1
$3.49K Hold
58
﹤0.01% 670
2024
Q4
$3.38K Hold
58
﹤0.01% 709
2024
Q3
$3.44K Hold
58
﹤0.01% 719
2024
Q2
$3.25K Hold
58
﹤0.01% 714
2024
Q1
$3.4K Buy
+58
New +$3.28K ﹤0.01% 704
2022
Q2
Sell
-600
Closed -$37K 917
2022
Q1
$37K Sell
600
-1
-0.2% -$60 0.01% 396
2021
Q4
$40K Buy
601
+1
+0.2% +$64 0.01% 395
2021
Q3
$38K Hold
600
0.01% 383
2021
Q2
$36K Hold
600
0.01% 405
2021
Q1
$33K Hold
600
0.01% 429
2020
Q4
$33K Sell
600
-48
-7% -$2.51K 0.01% 402
2020
Q3
$32K Buy
648
+48
+8% +$2.32K 0.01% 343
2020
Q2
$26K Hold
600
0.01% 263
2020
Q1
$22K Buy
+600
New +$25.3K 0.01% 144

Other funds holding IHI

Carolinas Wealth Consulting's IHI Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of iShares US Medical Devices ETF (IHI) in Q2 2025, closing a stake of 58 shares — an estimated $3.49K sold.

Carolinas Wealth Consulting first reported a position in IHI in Q1 2020 and held it in 14 quarters. The position peaked at $40K in Q4 2021. 546 funds tracked by Wall St. Rank hold IHI as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining iShares US Medical Devices ETF position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 58 iShares US Medical Devices ETF shares in Q2 2025, an estimated $3.49K.
  • Carolinas Wealth Consulting first reported a position in iShares US Medical Devices ETF in Q1 2020 and held it in 14 quarters.
  • Carolinas Wealth Consulting's iShares US Medical Devices ETF position peaked at $40K in Q4 2021.
  • 546 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.